Skip to content

Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms

Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02335567
Acronym
3TMR
Enrollment
162
Registered
2015-01-09
Start date
2012-06-30
Completion date
2016-01-31
Last updated
2016-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Plaque Hemorrhage Appearance

Brief summary

To compare two competing newly designed 3D sequences for black blood carotid plaque imaging techniques with the industry standard 2D sequnce for black blood.

Detailed description

To utilize a 3D sequence instead of the usual 2D commonly standard industry sequence that is supplied by the various manufacturers. Patients with greater than 50% stenosis that are 3T compatible are imaged using the two sequences to compare which sequences better visualize the plaque and it's characteristics The purpose is to validate the ability of the new 3D sequence to detect and measure any plaque hemorrhage as well as to identify region sof Type 1 hemorrhage.

Interventions

OTHERthere is no intervention

Sponsors

Michigan State University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with 50% stenosis of the carotid arteries that are safe to undergo MRI imaging

Exclusion criteria

* Patients that are determined to no be safe to undergo MR imaging due to implants

Design outcomes

Primary

MeasureTime frameDescription
Appearance of intraplaque hemorrhage1 day of scanwhat radiologist interperts

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026